What's in Coordinación de Investigación en Salud, Mexico's pipeline?

Coordinación de Investigación en Salud, Mexico has 9 drugs in our index: 3 marketed, 0 filed, 1 in Phase 3, 1 in Phase 2, 4 in Phase 1.

Which companies overlap with Coordinación de Investigación en Salud, Mexico's portfolio?

Top competitors by shared drug class: Ain Shams University.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/coordinaci-n-de-investigaci-n-en-salud-mexico.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Coordinación de Investigación en Salud, Mexico — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Coordinación de Investigación en Salud, Mexico pipeline: 3 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 1 Phase 3 1 Phase 2 4 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Area
Telmisartan plus Captopril	Telmisartan plus Captopril	marketed
Triticum Aestivum	Triticum Aestivum	marketed		Nutritional Support / Immunomodulation
starch tablets	starch tablets	marketed		Nutritional supplement / Pharmaceutical excipient
Collagen-PVP	Collagen-PVP	phase 3	Biomaterial/Wound healing agent	Wound Care/Tissue Regeneration

Therapeutic area mix

Infectious Disease · 1
Nutritional Support / Immunomodulation · 1
Nutritional supplement / Pharmaceutical excipient · 1
Wound Care/Tissue Regeneration · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ain Shams University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Coordinación de Investigación en Salud, Mexico:

Cite this brief

Drug Landscape (2026). Coordinación de Investigación en Salud, Mexico — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/coordinaci-n-de-investigaci-n-en-salud-mexico. Accessed 2026-05-17.